Source: Pharmceutical Business Review
Date: 17th January 2007
Summary:
Geron Corporation has said that studies suggest that the its stem cell therapeutic produces multiple nerve growth factors that stimulate the survival and regeneration of neurons damaged during spinal cord injury.
No comments:
Post a Comment